Pages that link to "Q36905256"

The following pages link to Uncoupling between noradrenergic and serotonergic neurons as a molecular basis of stable changes in behavior induced by repeated drugs of abuse (Q36905256):

Displaying 41 items.

• Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine (Q24605833) (← links)
• The Combination of Marketed Antagonists of α1b-Adrenergic and 5-HT2A Receptors Inhibits Behavioral Sensitization and Preference to Alcohol in Mice: A Promising Approach for the Treatment of Alcohol Dependence (Q28550709) (← links)
• Observational study to calculate addictive risk to opioids: a validation study of a predictive algorithm to evaluate opioid use disorder (Q33719240) (← links)
• Abnormal cortical responses to somatosensory stimulation in medication-overuse headache (Q33782357) (← links)
• Biogenic amines and their metabolites are differentially affected in the Mecp2-deficient mouse brain (Q33910475) (← links)
• Is love passion an addictive disorder? (Q34022758) (← links)
• The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine (Q34025177) (← links)
• The kappa opioid receptor: from addiction to depression, and back. (Q34650892) (← links)
• Serotonergic mechanism underlying tranylcypromine enhancement of nicotine self‐administration (Q34758170) (← links)
• Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat. (Q34791678) (← links)
• Nicotine Alters Limbic Function in Adolescent Rat by a 5-HT1A Receptor Mechanism (Q34988469) (← links)
• Amphetamine action at the cocaine- and antidepressant-sensitive serotonin transporter is modulated by αCaMKII. (Q35649527) (← links)
• Adding Genetic Testing to Evidence-Based Guidelines to Determine the Safest and Most Effective Chronic Pain Treatment for Injured Workers (Q36424264) (← links)
• Opioid receptors: distinct roles in mood disorders (Q36675341) (← links)
• Zebrafish: a model for the study of addiction genetics (Q37387341) (← links)
• Opponency revisited: competition and cooperation between dopamine and serotonin (Q37794770) (← links)
• α1-Adrenergic receptor subtypes in the central nervous system: insights from genetically engineered mouse models. (Q38189549) (← links)
• Adolescent amphetamine exposure elicits dose-specific effects on monoaminergic neurotransmission and behaviour in adulthood. (Q39690205) (← links)
• Validation Study of a Predictive Algorithm to Evaluate Opioid Use Disorder in a Primary Care Setting (Q41544475) (← links)
• Effects of repeated dosing with mechanistically distinct antinociceptive ligands in a rat model of neuropathic spinal cord injury pain (Q41692444) (← links)
• A functional role for the dopamine D3 receptor in the induction and expression of behavioural sensitization to ethanol in mice (Q43296885) (← links)
• Repeated exposure to MDMA triggers long-term plasticity of noradrenergic and serotonergic neurons (Q43587260) (← links)
• Availability of dopamine and serotonin transporters in opioid-dependent users—a two-isotope SPECT study (Q44330405) (← links)
• Glutamate input to noradrenergic neurons plays an essential role in the development of morphine dependence and psychomotor sensitization (Q44394260) (← links)
• The amphetamine sensitization model of schizophrenia symptoms and its effect on schedule-induced polydipsia in the rat. (Q44600763) (← links)
• Mifepristone treatment affects the response to repeated amphetamine injections, but does not attenuate the expression of sensitization. (Q44842959) (← links)
• Increased alcohol consumption in rats after subchronic antidepressant treatment (Q45387871) (← links)
• Hematological, immunological and neurochemical effects of chronic amphetamine treatment in male rats. (Q45934388) (← links)
• Inhibition of monoamine oxidases desensitizes 5-HT1A autoreceptors and allows nicotine to induce a neurochemical and behavioral sensitization. (Q46142247) (← links)
• Differential susceptibility to ethanol and amphetamine sensitization in dopamine D3 receptor-deficient mice (Q46190185) (← links)
• A prospective, longitudinal study to evaluate the clinical utility of a predictive algorithm that detects risk of opioid use disorder (Q47555162) (← links)
• Blockade of ethanol-induced behavioral sensitization by sodium butyrate: descriptive analysis of gene regulations in the striatum. (Q48127195) (← links)
• Cortical response to somatosensory stimulation in medication overuse headache patients is influenced by angiotensin converting enzyme (ACE) I/D genetic polymorphism (Q48341994) (← links)
• Elevated salivary α-amylase and cortisol levels in unremitted and remitted depressed patients (Q48974604) (← links)
• The administration of atomoxetine during alcohol deprivation induces a time-limited increase in alcohol consumption after relapse (Q50632978) (← links)
• Traumatic stress in rats induces noradrenergic-dependent long-term behavioral sensitization: role of individual differences and similarities with dependence on drugs of abuse. (Q52302818) (← links)
• Offline encoding impaired by epigenetic regulations of monoamines in the guided propagation model of autism (Q60044381) (← links)
• Post Traumatic Stress Disorder and Substance Use Disorder as Two Pathologies Affecting Memory Reactivation: Implications for New Therapeutic Approaches (Q64257801) (← links)
• Behavioral and Noradrenergic Sensitizations in Vulnerable Traumatized Rats Suggest Common Bases with Substance Use Disorders (Q88651597) (← links)
• d-Amphetamine and methylmercury exposure during adolescence alters sensitivity to monoamine uptake inhibitors in adult mice (Q91623190) (← links)
• Understanding Addiction Using Animal Models (Q92069642) (← links)